Storia in 19 fonti

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective treatment

Raccontata da

scientificamerican.com

independent.co.uk

nbcnews.com+7 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

thestar.comStai leggendo9 h fa

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective treatment

originale

Timeline cronologica

mercoledì 26 agosto 2026·forbes.com
FDA Approves New Pancreatic Cancer Drug After Stunning Trial Results
The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.
mercoledì 26 agosto 2026·forbes.com
FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque
Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

Confronto fonti

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

Timeline cronologica

FDA Approves New Pancreatic Cancer Drug After Stunning Trial Results

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA Approves Landmark Pancreatic Cancer Drug That's Shown To Improve Survival

New hope for pancreatic cancer patients after FDA approves drug to improve survival

FDA approves new pancreatic cancer drug that could extend patients' lives

Pancreatic cancer drug Daraxonrasib gets approval from FDA: All you need to know

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA approves new pancreatic cancer drug expected to usher in new era of treatment

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA approves breakthrough drug to treat advanced pancreatic cancer

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease

New hope for pancreatic cancer patients after FDA approves drug to improve survival

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

FDA approves groundbreaking pancreatic cancer drug

FDA approves new treatment for those with advanced pancreatic cancer - UPI.com

FDA aprueba nuevo fármaco contra cáncer de páncreas

FDA Approves Landmark Pancreatic Cancer Drug That's Shown To Improve Survival

FDA approves breakthrough pancreatic cancer drug proven to extend survival

Why Wall Street sees a $39,800 pancreatic cancer pill as proof of a much bigger bet | Fortune